产品说明
包装
5, 25 g in poly bottle
生化/生理作用
Inhibits action of acetylcholine at post-ganglionic synapses; muscarinic acetylcholine receptor antagonist; antispasmodic; reduces gastric acid secretion.
特点和优势
This compound was developed by Shire. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
基本信息
| 线性分子式 | C23H30NO3Br |
| 分子量 | 448.39 |
| EC 号 | 200-030-6 |
| MDL编号 | MFCD00050291 |
| PubChem化学物质编号 | 24278660 |
| NACRES | NA.77 |
产品性质
| 质量水平 | 200 |
| 测定 | ≥97% (TLC) |
| 形式 | powder |
| 颜色 | white to off-white |
| 溶解性 | H2O: 50 mg/mL |
| 创始人 | Shire |
| SMILES string | [Br-].CC(C)[N+](C)(CCOC(=O)C1c2ccccc2Oc3ccccc13)C(C)C |
| InChI | 1S/C23H30NO3.BrH/c1-16(2)24(5,17(3)4)14-15-26-23(25)22-18-10-6-8-12-20(18)27-21-13-9-7-11-19(21)22;/h6-13,16-17,22H,14-15H2,1-5H3;1H/q+1;/p-1 |
| InChI key | XLBIBBZXLMYSFF-UHFFFAOYSA-M |
| Gene Information | human ... CHRM1(1128), CHRM2(1129), CHRM3(1131), CHRM4(1132), CHRM5(1133) |
安全信息
| 象形图 |  |
| 警示用语： | Warning |
| 危险声明 | H302 |
| 预防措施声明 | P264 - P270 - P301 + P312 - P501 |
| 危险分类 | Acute Tox. 4 Oral |
| 储存分类代码 | 13 - Non Combustible Solids |
| WGK | WGK 3 |
| 闪点(F) | Not applicable |
| 闪点(C) | Not applicable |
| 个人防护装备 | dust mask type N95 (US), Eyeshields, Faceshields, Gloves |
m.cnreagent.com
